Olof Heimburger

Olof Heimburger

UNVERIFIED PROFILE

Are you Olof Heimburger?   Register this Author

Register author
Olof Heimburger

Olof Heimburger

Publications by authors named "Olof Heimburger"

Are you Olof Heimburger?   Register this Author

100Publications

1466Reads

10Profile Views

Copeptin is independently associated with vascular calcification in chronic kidney disease stage 5.

BMC Nephrol 2020 Feb 7;21(1):43. Epub 2020 Feb 7.

Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Campus Flemingsberg, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12882-020-1710-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006395PMC
February 2020

Bone mineral density at different sites and 5 years mortality in end-stage renal disease patients: A cohort study.

Bone 2020 Jan 24;130:115075. Epub 2019 Oct 24.

Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bone.2019.115075DOI Listing
January 2020

Serum 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage, is associated with mortality independent of inflammation in chronic kidney disease.

Eur J Intern Med 2019 Oct 9;68:60-65. Epub 2019 Aug 9.

Division of Renal Medicine and Baxter Novum, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Campus Flemingsberg, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejim.2019.07.035DOI Listing
October 2019

Uraemic symptom burden and clinical condition in women and men of ≥65 years of age with advanced chronic kidney disease: results from the EQUAL study.

Nephrol Dial Transplant 2019 07;34(7):1189-1196

ERA-EDTA Registry, Department of Medical Informatics, Academic Medical Center, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfy155DOI Listing
July 2019

Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study.

Nephrol Dial Transplant 2019 03;34(3):442-448

Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Campus Flemingsberg, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfx371DOI Listing
March 2019

Differences in association of lower bone mineral density with higher coronary calcification in female and male end-stage renal disease patients.

BMC Nephrol 2019 02 18;20(1):59. Epub 2019 Feb 18.

Division of Renal Medicine and Baxter Novum, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12882-019-1235-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380026PMC
February 2019

Inverse J-shaped relation between coronary arterial calcium density and mortality in advanced chronic kidney disease.

Nephrol Dial Transplant 2018 Dec 7. Epub 2018 Dec 7.

Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Campus Flemingsberg, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://fdslive.oup.com/www.oup.com/pdf/production_in_progres
Publisher Site
http://dx.doi.org/10.1093/ndt/gfy352DOI Listing
December 2018

Lung Dysfunction and Mortality in Patients with Chronic Kidney Disease.

Kidney Blood Press Res 2018 29;43(2):522-535. Epub 2018 Mar 29.

Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Campus Flemingsberg, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000488699DOI Listing
October 2018

Plasma Beta-Trace Protein as a Marker of Residual Renal Function: The Effect of Different Hemodialysis Modalities and Intra-Individual Variability over Time.

Kidney Blood Press Res 2017 22;42(5):877-885. Epub 2017 Nov 22.

Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000484537DOI Listing
August 2018

Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients.

BMC Pharmacol Toxicol 2018 06 25;19(1):33. Epub 2018 Jun 25.

Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, SE-141 86, Stockholm, Sweden.

View Article

Download full-text PDF

Source
https://bmcpharmacoltoxicol.biomedcentral.com/articles/10.11
Publisher Site
http://dx.doi.org/10.1186/s40360-018-0221-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020207PMC
June 2018

Do metabolic derangements in end-stage polycystic kidney disease differ versus other primary kidney diseases?

Nephrology (Carlton) 2018 Jan;23(1):31-36

Division of Renal Medicine and Baxter Novum, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/nep.12927DOI Listing
January 2018

Clinical global assessment of nutritional status as predictor of mortality in chronic kidney disease patients.

PLoS One 2017 6;12(12):e0186659. Epub 2017 Dec 6.

Division of Renal Medicine and Baxter Novum, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0186659PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718431PMC
January 2018

Total and bone-specific alkaline phosphatase are associated with bone mineral density over time in end-stage renal disease patients starting dialysis.

J Nephrol 2017 Apr 18;30(2):255-262. Epub 2016 Mar 18.

Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Hospital Huddinge, Karolinska University, KFC, Novum, 141 86, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40620-016-0292-7DOI Listing
April 2017

Does statins promote vascular calcification in chronic kidney disease?

Eur J Clin Invest 2017 Feb;47(2):137-148

Division of Renal Medicine and Baxter Novum, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/eci.12718DOI Listing
February 2017

Vertebral bone density associates with coronary artery calcification and is an independent predictor of poor outcome in end-stage renal disease patients.

Bone 2016 11 9;92:50-57. Epub 2016 Aug 9.

Division of Renal Medicine and Baxter Novum, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bone.2016.08.007DOI Listing
November 2016

Dialysis modality and nutritional status are associated with variability of inflammatory markers.

Nephrol Dial Transplant 2016 08 24;31(8):1320-7. Epub 2016 May 24.

Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfw104DOI Listing
August 2016

Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD.

Clin J Am Soc Nephrol 2016 07 8;11(7):1163-72. Epub 2016 Jun 8.

Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.10441015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934843PMC
July 2016

Increased Levels of Modified Advanced Oxidation Protein Products Are Associated with Central and Peripheral Blood Pressure in Peritoneal Dialysis Patients.

Perit Dial Int 2015 Jul-Aug;35(4):460-70. Epub 2014 Mar 1.

Department of Clinical Science, Intervention and Technology, Divisions of Renal Medicine and Baxter Novum, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden

View Article

Download full-text PDF

Source
http://www.pdiconnect.com/cgi/doi/10.3747/pdi.2013.00064
Publisher Site
http://dx.doi.org/10.3747/pdi.2013.00064DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520729PMC
May 2016

Oxidative DNA damage and mortality in hemodialysis and peritoneal dialysis patients.

Perit Dial Int 2015 Mar-Apr;35(2):206-15. Epub 2014 Mar 1.

Department of Clinical Science, Intervention and Technology, Divisions of Renal Medicine and Baxter Novum, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3747/pdi.2013.00259DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406316PMC
April 2016

A cohort study of insulin-like growth factor 1 and mortality in haemodialysis patients.

Clin Kidney J 2016 Feb 26;9(1):148-52. Epub 2015 Nov 26.

Division of Renal Medicine and Baxter Novum, Department of Clinical Science , Intervention and Technology, Karolinska Institutet , Huddinge , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ckj/sfv118DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720197PMC
February 2016

Determinants of N-terminal pro-brain natriuretic peptide variation in hemodialysis patients and prediction of survival.

Blood Purif 2014 8;37(2):138-45. Epub 2014 Apr 8.

Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000360267DOI Listing
August 2015

Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients.

Nephrol Dial Transplant 2015 Jan 28;30(1):84-91. Epub 2014 Jul 28.

Divisions of Renal Medicine and Baxter Novum, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfu259DOI Listing
January 2015

Comparative associations of muscle mass and muscle strength with mortality in dialysis patients.

Clin J Am Soc Nephrol 2014 Oct 29;9(10):1720-8. Epub 2014 Jul 29.

Divisions of Renal Medicine and Baxter Novum, and Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.10261013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186520PMC
October 2014

The use of estimated glomerular filtration rate for dose adjustment of medications in the elderly.

Drugs Aging 2014 Jul;31(7):493-9

Department of Evidence Based Medicine, Renal Medicine at CLINTEC, Karolinska Institutet, Stockholm County Council, Box 17533, 118 91, Stockholm, Sweden,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40266-014-0187-zDOI Listing
July 2014

Subclinical atherosclerosis, endothelial function, and serum inflammatory markers in chronic kidney disease stages 3 to 4.

Angiology 2014 May 7;65(5):443-9. Epub 2013 Apr 7.

1Department of Cardiology, Oslo University Hospital Ullevål, Oslo University, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0003319713483000DOI Listing
May 2014

Determinants of fibroblast growth factor-23 and parathyroid hormone variability in dialysis patients.

Am J Nephrol 2013 27;37(5):462-71. Epub 2013 Apr 27.

Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000350537DOI Listing
February 2014

IGF-1 and survival in ESRD.

Clin J Am Soc Nephrol 2014 Jan 31;9(1):120-7. Epub 2013 Oct 31.

Divisions of Baxter Novum and Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.02470213DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878692PMC
January 2014

[Drug dosage should be based on renal function].

Lakartidningen 2013 Nov 20-26;110(47):2119-20

Njurmedicinska kliniken, Karolinska universitetssjukhuset, Huddinge, Karolinska institutet, Stockholm.

View Article

Download full-text PDF

Source
January 2014

[It is better use a modern formula than being formal].

Lakartidningen 2013 Nov 20-26;110(47):2122

View Article

Download full-text PDF

Source
January 2014

Nonthyroidal illness: a risk factor for coronary calcification and arterial stiffness in patients undergoing peritoneal dialysis?

J Intern Med 2013 Dec 15;274(6):584-93. Epub 2013 Jul 15.

Department of Clinical Epidemiology, Leiden University Medical Centre, Leiden, The Netherlands; Baxter Novum, CLINTEC, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/joim.12107DOI Listing
December 2013

Determinants and survival implications of low bone mineral density in end-stage renal disease patients.

J Nephrol 2013 May-Jun;26(3):485-94. Epub 2012 Sep 13.

Division of Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://www.jnephrol.com/article/determinants-and-survival-im
Publisher Site
http://dx.doi.org/10.5301/jn.5000185DOI Listing
November 2013

Subclinical versus overt obesity in dialysis patients: more than meets the eye.

Nephrol Dial Transplant 2013 Nov;28 Suppl 4:iv175-81

Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gft024DOI Listing
November 2013

Self-rated appetite as a predictor of mortality in patients with stage 5 chronic kidney disease.

J Ren Nutr 2013 Mar 26;23(2):106-13. Epub 2012 Jun 26.

Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.jrn.2012.04.009DOI Listing
March 2013

Statins and lipid-lowering strategies in PD.

Authors:
Olof Heimbürger

Contrib Nephrol 2012 25;178:106-110. Epub 2012 May 25.

Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000337828DOI Listing
October 2012

Essential polyunsaturated fatty acids, inflammation and mortality in dialysis patients.

Nephrol Dial Transplant 2012 Sep 7;27(9):3615-20. Epub 2012 May 7.

Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfs132DOI Listing
September 2012

Serum albumin as predictor of nutritional status in patients with ESRD.

Clin J Am Soc Nephrol 2012 Sep 21;7(9):1446-53. Epub 2012 Jun 21.

Divisions of Baxter Novum and Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.10251011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430958PMC
September 2012

Peritoneal dialysis.

Int J Nephrol 2011 5;2011:218974. Epub 2012 Apr 5.

Department of Nephrology, Inonu University, 44280 Malatya, Turkey.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4061/2011/218974DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328157PMC
August 2012

Metabolism of alprazolam (a marker of CYP3A4) in hemodialysis patients with persistent inflammation.

Eur J Clin Pharmacol 2012 May 9;68(5):571-7. Epub 2011 Dec 9.

Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00228-011-1163-8
Publisher Site
http://dx.doi.org/10.1007/s00228-011-1163-8DOI Listing
May 2012

Plasma fatty acids in chronic kidney disease: nervonic acid predicts mortality.

J Ren Nutr 2012 Mar 20;22(2):277-83. Epub 2011 Jul 20.

Cardiovascular Health Research Center, Sanford Research, Sioux Falls, South Dakota 57105, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10512276110009
Publisher Site
http://dx.doi.org/10.1053/j.jrn.2011.05.005DOI Listing
March 2012

Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease.

Nephrol Dial Transplant 2012 Feb 26;27(2):709-15. Epub 2011 May 26.

Department of Clinical Science, Intervention and Technology, Division of Renal Medicine, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfr288DOI Listing
February 2012

Inverse relationship between the inflammatory marker pentraxin-3, fat body mass, and abdominal obesity in end-stage renal disease.

Clin J Am Soc Nephrol 2011 Dec;6(12):2785-91

Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, KarolinskaInstitutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.02320311DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255358PMC
December 2011

Expression of osteoprotegerin in human fat tissue; implications for chronic kidney disease.

Eur J Clin Invest 2011 May 3;41(5):498-506. Epub 2010 Dec 3.

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2362.2010.02432.xDOI Listing
May 2011

Circulating follistatin in patients with chronic kidney disease: implications for muscle strength, bone mineral density, inflammation, and survival.

Clin J Am Soc Nephrol 2011 May 24;6(5):1001-8. Epub 2011 Feb 24.

Division of Baxter Novum, Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.10511110DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087764PMC
May 2011

Mathematical modeling of the glucose-insulin system during peritoneal dialysis with glucose-based fluids.

ASAIO J 2011 Jan-Feb;57(1):41-7

Institute of Biocybernetics and Biomedical Engineering, Warsaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MAT.0b013e3181fe5b76DOI Listing
April 2011

Influence of erythropoiesis-stimulating agents on glycated hemoglobin in nondiabetic kidney diseases at the start of dialysis.

Am J Nephrol 2011 3;33(1):17-24. Epub 2010 Dec 3.

Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000322608DOI Listing
April 2011

Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patients.

Kidney Int 2011 Apr 22;79(7):749-56. Epub 2010 Dec 22.

Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ki.2010.487DOI Listing
April 2011

Bicarbonate-based peritoneal dialysis solution has less effect on ingestive behavior than lactate-based peritoneal dialysis solution.

Perit Dial Int 2009 Nov-Dec;29(6):656-63

Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

View Article

Download full-text PDF

Source
January 2011

Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease.

Nephrol Dial Transplant 2011 Jan 11;26(1):184-90. Epub 2010 Jul 11.

Division of Renal Medicine, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfq397DOI Listing
January 2011

Clinical importance of an elevated circulating chemerin level in incident dialysis patients.

Nephrol Dial Transplant 2010 Dec 13;25(12):4017-23. Epub 2010 Jun 13.

Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfq329DOI Listing
December 2010

Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship?

Nephrol Dial Transplant 2010 Sep 5;25(9):3033-8. Epub 2010 Apr 5.

Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfq191DOI Listing
September 2010

Evaluation of peritoneal membrane characteristics: clinical advice for prescription management by the ERBP working group.

Nephrol Dial Transplant 2010 Jul 4;25(7):2052-62. Epub 2010 Mar 4.

Renal Division, University Hospital Ghent, Ghent, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfq100DOI Listing
July 2010

Recovery of renal function after one-year of dialysis treatment: case report and registry data.

Int J Nephrol 2010 Jun 17;2010:817836. Epub 2010 Jun 17.

Dialysis Unit, Sophiahemmet, Karolinska University Hospital, P.O. Box 5605, 114 86 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4061/2010/817836DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003972PMC
June 2010

High-flux or low-flux dialysis: a position statement following publication of the Membrane Permeability Outcome study.

Nephrol Dial Transplant 2010 Apr 22;25(4):1230-2. Epub 2009 Dec 22.

Renal Unit, St James's University Hospital, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfp626DOI Listing
April 2010

Influence of the CYP2D6 polymorphism and hemodialysis on codeine disposition in patients with end-stage renal disease.

Eur J Clin Pharmacol 2010 Mar 26;66(3):269-73. Epub 2009 Nov 26.

Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-009-0759-8DOI Listing
March 2010

Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels.

Nephrol Dial Transplant 2010 Mar 30;25(3):901-6. Epub 2009 Nov 30.

Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfp587DOI Listing
March 2010

Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis.

Nephrol Dial Transplant 2010 Feb 17;25(2):562-8. Epub 2009 Sep 17.

Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfp492DOI Listing
February 2010

Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease.

J Nephrol 2009 Nov-Dec;22(6):774-82

Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://www.sin-italy.org/web%5Ceventi%5CSIN%5Carchivio%5Cjn%
Web Search
February 2010

Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients.

Am J Kidney Dis 2009 Dec 6;54(6):1072-80. Epub 2009 Sep 6.

Division of Renal Diseases and Hypertension, George Washington University, Washington, DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ajkd.2009.06.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2787958PMC
December 2009

Low levels of IgM antibodies against phosphorylcholine-A increase mortality risk in patients undergoing haemodialysis.

Nephrol Dial Transplant 2009 Nov 23;24(11):3454-60. Epub 2009 Jun 23.

Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfp309DOI Listing
November 2009

Associations of VEGF and its receptors sVEGFR-1 and -2 with cardiovascular disease and survival in prevalent haemodialysis patients.

Nephrol Dial Transplant 2009 Nov 26;24(11):3468-73. Epub 2009 Jun 26.

1Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfp315DOI Listing
November 2009

N-terminal pro-brain natriuretic peptide independently predicts protein energy wasting and is associated with all-cause mortality in prevalent HD patients.

Am J Nephrol 2009 12;29(6):516-23. Epub 2008 Dec 12.

Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000185628DOI Listing
September 2009

How to assess peritoneal transport: which test should we use?

Authors:
Olof Heimbürger

Contrib Nephrol 2009 3;163:82-89. Epub 2009 Jun 3.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000223784DOI Listing
September 2009

How should we measure peritoneal dialysis adequacy in the clinic.

Authors:
Olof Heimbürger

Contrib Nephrol 2009 3;163:140-146. Epub 2009 Jun 3.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000223792DOI Listing
September 2009

Lipid disorders, statins and the peritoneal membrane.

Authors:
Olof Heimbürger

Contrib Nephrol 2009 3;163:177-182. Epub 2009 Jun 3.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000223797DOI Listing
September 2009

Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.

Am J Kidney Dis 2009 Jun 25;53(6):1024-33. Epub 2009 Apr 25.

Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ajkd.2009.02.008DOI Listing
June 2009

[Choose the right method fo estimation of kidney function. The nature of the problem determines which method should be used].

Lakartidningen 2009 Feb 11-17;106(7):420-1

Karolinska Universitetssjukhuset, Stockholm.

View Article

Download full-text PDF

Source
April 2009

Low serum testosterone increases mortality risk among male dialysis patients.

J Am Soc Nephrol 2009 Mar 14;20(3):613-20. Epub 2009 Jan 14.

Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1681/ASN.2008060664DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653676PMC
March 2009